VolitionRx Limited

Healthcare · Medical Devices · United States

Last price 0.1953 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.77M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s c...